In our most recent article, Senior Associate and Patent Attorney, Sarah Gibbs, and Trainee Patent Attorney, Jack Braithwaite, discuss how the revocation of Dexcom’s patent on CGM tech by the Unified Patent Court, marked a significant victory for Abbott, in their ongoing patent battle.
Read more
As the UK wine industry continues to grow, the need to protect the unique characteristics and reputations of British wines has never been more critical. In this article, Trade Mark Attorney, Claire Bothma, explores why the UK wine industry is at a pivotal moment when it comes to IP, and details how a UK wine producer can protect a brand’s identity and competitive edge.
Read more
Senior Associate, Edward Rainsford, discusses a referral brought to the Enlarged Board of Appeal. The Enlarged Board of Appeal has been presented with several questions about the extent to which the description and figures should be consulted when interpreting the claims of a patent application. The upcoming decision could clarify claim interpretation in future cases.
Read more
Clinical trials in the UK are governed by what can at times appear like, a complex arrangement of provisions and exemptions. In this article, we summarise these provisions and provide a guide on how to ensure that intellectual property rights are not infringed in the process of carrying out a clinical trial.
Read more
In this article, Appleyard Lees', Senior Associate and Patent Attorney, Sarah Gibbs, explores how the launch of two recently developed malaria vaccines, RTS,S and R21, marks a critical milestone in combating malaria. Sarah explores how integrating these vaccines with existing control measures in Africa sets out a promising path towards near-eradication of malaria.
Read more
The first revocation decision from the Unified Patent Court (UPC) has seen a win for Sanofi and Regeneron in a dispute with Amgen over cholesterol lowering drugs.
Read more
In this article, we explore and discuss emerging technological innovations designed to enhance care for individuals affected by Alzheimer's disease and dementia. Appleyard Lees supports organisations that create or enable innovation that makes life better and is proud to be supporting the UK's leading dementia charity, Alzheimer’s Society. Alzheimer’s Society are an organisation striving to eliminate the devastating impact of dementia worldwide, as our charity of the year.
Read more
The UK Supreme Court has provided guidance on the circumstances upon which directors may be personally liable as an accessory to a tort (trade mark infringement is a tortious act) committed by their company.
Read more
Romania deposited its instrument of ratification of the Unified Patent Court Agreement on 31 May 2024, becoming the 18th member state to ratify the Agreement.
Read more
Sarah Gibbs discusses a recent decision from the European Patent Office on how intermediate generalisations should be assessed for added matter.
Read more
Getting a patent granted for your innovation can be a costly process. There are, of course, fees associated with the work your patent attorneys do to advise you, to prepare your patent application, and to work with the Patent Office to obtain a granted patent for you.
Read more
